Cargando…
Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases
This study aimed to investigate the use of Plasma Rich in Growth Factors (PRGF) associated with tissue ReGeneraTing Agent (RGTA) drops for the treatment of noninfectious corneal ulcers. RGTA treatment was applied (one drop every two days); however, if ulcer closure was not achieved, PRGF eye drops t...
Autores principales: | Sánchez-Ávila, Ronald M., Uribe-Badillo, Edmar, Fernández-Vega González, Carlos, Muruzabal, Francisco, de la Sen-Corcuera, Borja, Baamonde, Begoña, Quirós, Luis M., Anitua, Eduardo, Merayo-Lloves, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293442/ https://www.ncbi.nlm.nih.gov/pubmed/34287367 http://dx.doi.org/10.3390/vision5030034 |
Ejemplares similares
-
Plasma rich in growth factors versus Mitomycin C in photorefractive keratectomy
por: Sanchez-Avila, Ronald M., et al.
Publicado: (2021) -
Optimization of a Plasma Rich in Growth Factors Membrane for the Treatment of Inflammatory Ocular Diseases
por: Anitua, Eduardo, et al.
Publicado: (2022) -
Plasma Rich in Growth Factors Enhances Cell Survival after in Situ Retinal Degeneration
por: Suárez-Barrio, Carlota, et al.
Publicado: (2020) -
Differential Protein Content between Fresh and Freeze-Dried Plasma Rich in Growth Factors Eye Drops
por: Anitua, Eduardo, et al.
Publicado: (2022) -
Plasma Rich in Growth Factors for the Treatment of Cicatrizing Conjunctivitis
por: de la Sen-Corcuera, Borja, et al.
Publicado: (2020)